Navigation Links
Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters

PRINCETON, N.J., March 19, 2013 /PRNewswire-iReach/ -- PendoTECH, a company dedicated to designing products to optimize the bioprocess, announced today that it has relocated its regional headquarters to an expanded facility in Princeton, NJ.  The office space will serve as the company's local base of operation now that it has moved out of its former facility of 5 years.

"We are pleased to announce our relocation within the Princeton, NJ area; home to some of the biggest pharmaceutical companies in the country and in the heart of the state designated industry cluster known as Einstein's Alley ( )," shares PendoTECH's James Furey .  "The new office includes upgraded amenities such as client meeting rooms, expanded reception area, product showroom, a state-of-the-art laboratory and space for future growth.  The move will enable greater access to our current and emerging clients."

A pioneer in the area of in-line, low cost sensory technology, PendoTECH is one of the most recognized brands known for enhancing the production process for biopharmaceuticals such as antibodies, recombinant proteins, vaccines, gene therapy and cell therapy products.   The need for a larger office became more pressing due to a steady increase in product demands. 

About PendoTECH
PendoTECH is committed to providing value-added products and services to companies in the biopharmaceutical industry for enhanced development and production of products derived mainly from biological systems.   Products include Single Use Pressure Sensors, PressureMAT- a monitor, alarm, and transmitter system designed for use with the pressure sensors, and our integrated Process Control Systems for applications such as TFF/Crossflow Filtration, Filter Screening, Virus-Depth Filtration, Bioreactor Pressure Control/Monitoring and more. 

As the number of biologicals produced by cell culture increases and the industry matures, new technologies and process approaches are available for comparison to the existing ones for evaluation of enhanced production output and reduced cost of goods.  Contact us at or 609-799-2299 for more information. 

Media Contact: Jim Furey PendoTECH, 609-799-2299,

News distributed by PR Newswire iReach:

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
2. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
3. Amgen to Present at the Baird Growth Stock Conference
4. Veeva Systems Announces Dramatic Growth in Europe
5. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
6. Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
7. Millennium Surgical Corp. Announces Sales Figures, Growth
8. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
9. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
10. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
11. Perrigo Company To Present At The William Blair Growth Stock Conference
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):